Vincent Linder,
Founder and President
BioMedical Consultant, Entrepreneur & Senior Biotech Executive with track record of success for biomedical devices. Partner with clients for value creation during all aspects of development of biomedical devices, from invention to commercialization.
Co-founder of Claros Diagnostics (a technology company spun out of Harvard University) with a successful $50M exit, completion of design & development activities, CE-mark and submission to FDA of a pre-market approval (PMA) as Chief Technology Officer of OPKO Diagnostics. The Claros® device is a point-of-care device that allows the quantitative determination of protein by immunoassay in a droplet of fingerstick blood. Technical and regulatory oversight for the launch of the 4Kscore®, a blood test for the early detection of prostate cancer.
Post-doctoral fellow at Harvard University (Prof. Whitesides), and Ph.D. in Switzerland from the Institute of Microtechnology, University of Neuchatel (Prof. de Rooij), in collaboration with the Insel University Hospital, and CSEM (Swiss Center of Electronics and Microtechnology).
|
|
|